Asset Details
Do you wish to reserve the book?
Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
Do you wish to request the book?
Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
2025
Overview
Cyclophilin (Cyp) inhibitors are of clinical interest in respect to their antiviral activities in the context of many viral infections including chronic hepatitis B and C. Cyps are a group of enzymes with peptidyl-prolyl isomerase activity (PPIase), known to be required for replication of diverse viruses including hepatitis B and C viruses (HBV and HCV). Amongst the Cyp family, the molecular mechanisms underlying the antiviral effects of CypA have been investigated in detail, but potential roles of other Cyps are less well studied in the context of viral hepatitis. Furthermore, most studies investigating the role of Cyps in viral hepatitis did not investigate the potential therapeutic effects of their inhibition in already-established infections but have rather been performed in the context of neo-infections. Here, we investigated the effects of genetically silencing Cyps on persistent HCV and HBV infections. We confirm antiviral effects of CypA and CypD knock down and demonstrate novel roles for CypG and CypH in HCV replication. We show, furthermore, that CypA silencing has a modest but reproducible impact on persistent HBV infections in cultured human hepatocytes.
Publisher
MDPI AG,MDPI
Subject
/ Antiviral Agents - pharmacology
/ Cloning
/ Cyclophilins - antagonists & inhibitors
/ Hepatitis B virus - drug effects
/ Hepatitis B virus - physiology
/ HIV
/ Human immunodeficiency virus
/ Humans
/ Liver
/ Microbiology and Parasitology
/ Proteins
/ Virology
/ Virus Replication - drug effects
/ Viruses
